Product Information
VENLAFAXINE HCL 50 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.0894 per EA under NDC 68382002001. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 13, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382002001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077653FDA Approved
6/13/2008
TE Code
AB
On Market Since
6/13/2008
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 50 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 75.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0894 per EA |
|---|---|
| All-time high | $0.4798 (Feb 12, 2014) |
| All-time low | $0.0537 (Jan 18, 2023) |
| 52-week high | $0.1047 |
| 52-week low | $0.0797 |
| Median price | $0.1872 |
| Average price | $0.2035 |
| Largest weekly change | +66.0% (Jun 19, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Venlafaxine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin and Norepinephrine Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 50 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.0894 per EA (NDC 68382002001), effective Sep 30, 2026.
How has the price of VENLAFAXINE HCL 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 50 MG TABLET has declined 75.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 50 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 50 MG TABLET has ranged from a low of $0.0537 (Jan 18, 2023) to a high of $0.4798 (Feb 12, 2014), with a median of $0.1872 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 50 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 50 MG TABLET?
VENLAFAXINE HCL 50 MG TABLET (NDC 68382002001) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.